First Time Loading...

T2 Biosystems Inc
NASDAQ:TTOO

Watchlist Manager
T2 Biosystems Inc Logo
T2 Biosystems Inc
NASDAQ:TTOO
Watchlist
Price: 3.72 USD 1.92% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

TTOO Price Targets Summary
T2 Biosystems Inc

Wall Street analysts forecast TTOO stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TTOO is 3.06 USD with a low forecast of 3.03 USD and a high forecast of 3.15 USD.

TTOO Lowest Forecast
Wall Street Target
3.03 USD
19% Downside
TTOO Average Forecast
Wall Street Target
3.06 USD
18% Downside
TTOO Highest Forecast
Wall Street Target
3.15 USD
15% Downside
Lowest
Price Target
3.03 USD
19% Downside
Average
Price Target
3.06 USD
18% Downside
Highest
Price Target
3.15 USD
15% Downside
T2 Biosystems Inc Competitors:
Price Targets
A
APGE
Apogee Therapeutics Inc
61% Upside
ARQT
Arcutis Biotherapeutics Inc
130% Upside
ASND
Ascendis Pharma A/S
34% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
35% Upside
A
APGE
Apogee Therapeutics Inc
61% Upside
ARQT
Arcutis Biotherapeutics Inc
130% Upside
ASND
Ascendis Pharma A/S
34% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
35% Upside
H
042520
Hans Biomed Corp
175% Upside
GNS
Genus PLC
47% Upside
BCYC
Bicycle Therapeutics PLC
79% Upside
BIOCON
Biocon Ltd
6% Downside

Revenue
Forecast

Revenue Estimate
T2 Biosystems Inc

For the last 8 years the compound annual growth rate for T2 Biosystems Inc's revenue is 12%. The projected CAGR for the next 3 years is 94%.

12%
Past Growth
94%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
T2 Biosystems Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
T2 Biosystems Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
What are analyst estimates?

See Also

Summary
TTOO intrinsic value, competitors valuation, and company profile.
DCF Valuation
TTOO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TTOO stock valuation using valuation multiples.
Wall Street Estimates
TTOO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TTOO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TTOO's stock price target?
Price Target
3.06 USD

According to Wall Street analysts, the average 1-year price target for TTOO is 3.06 USD with a low forecast of 3.03 USD and a high forecast of 3.15 USD.

What is T2 Biosystems Inc's Revenue forecast?
Projected CAGR
94%

For the last 8 years the compound annual growth rate for T2 Biosystems Inc's revenue is 12%. The projected CAGR for the next 3 years is 94%.

ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.